Please login to the form below

Not currently logged in
Email:
Password:

European Cancer Congress 2013

This page shows the latest European Cancer Congress 2013 news and features for those working in and with pharma, biotech and healthcare.

ECC 2013: Nintedanib data boosts Boehringer’s oncology ambitions

ECC 2013: Nintedanib data boosts Boehringer’s oncology ambitions

ECC 2013: Nintedanib data boosts Boehringer’ s oncology ambitions. Lung cancer drug shows extended overall survival in adenocarcinoma patients. ... Data from the LUME-Lung 1 study was presented at the European Cancer Congress in Amsterdam and showed

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics